Note: Beutlich Pharmaceuticals's revenues are gauged from an analysis of company filings.
Beutlich Pharmaceuticals's Income Statement (based on Industry Averages)
Beutlich Pharmaceuticals P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Trademark Applications
Trademark applications show the products and services that Beutlich Pharmaceuticals is developing and marketing.
Beutlich Pharmaceuticals doesn't have any recent trademark applications, indicating Beutlich Pharmaceuticals is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
HURRICAINE ONE Topical anesthetic sold in a unit dose delivery system
10/22/2009
HURRIPAK Periodontal kit consisting of topical anesthetic and syringes and syringe tips for application of the anesthetic all sold as a unit
10/26/2007
HURRIVIEW II Plaque discoloring dye for dental use
02/16/2006
See all trademarks and details in the Full Report.
Market Share of Beutlich Pharmaceuticals's Largest Competitors
A competitive analysis shows these companies are in the same general field as Beutlich Pharmaceuticals, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Beutlich Pharmaceuticals.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Beutlich Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.